Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2018, Article ID 8547364, 23 pages
https://doi.org/10.1155/2018/8547364
Review Article

An Overview of the Potential Therapeutic Applications of CO-Releasing Molecules

Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, QC, Canada H3A 3K6

Correspondence should be addressed to Ian S. Butler; ac.lligcm@reltub.nai

Received 16 March 2018; Revised 19 June 2018; Accepted 18 July 2018; Published 12 August 2018

Academic Editor: Francesco Paolo Fanizzi

Copyright © 2018 Aiten Ismailova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Motterlini, “Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities,” Circulation Research, vol. 90, no. 2, pp. 17e–24e, 2002. View at Publisher · View at Google Scholar
  2. R. Motterlini, B. Haas, and R. Foresti, “Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs),” Medical Gas Research, vol. 2, no. 1, p. 28, 2012. View at Publisher · View at Google Scholar
  3. S. H. Heinemann, T. Hoshi, M. Westerhausen, and A. Schiller, “Carbon monoxide–physiology, detection and controlled release,” Chemical Communications, vol. 50, no. 28, pp. 3644–3660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. S. Murray, C. Okegbe, Y. Gao et al., “The carbon monoxide releasing molecule CORM-2 attenuates Pseudomonas aeruginosa biofilm formation,” PLoS One, vol. 7, no. 4, Article ID e35499, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Adamson, Advanced Inorganic Chemistry, vol. 2, Wiley, New York, NY, USA, 6th edition, 1963.
  6. C. C. Romão, W. A. Blättler, J. D. Seixas, and G. J. L. Bernardes, “Developing drug molecules for therapy with carbon monoxide,” Chemical Society Reviews, vol. 41, no. 9, p. 3571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Daniel and S. Seixas, “Development of CO-releasing molecules for the treatment of inflammatory diseases alfama development of CO-releasing molecules for the treatment of inflammatory diseases,” New University of Lisbon, Lisbon, Portugal, 2011, Ph.D. dissertation. View at Google Scholar
  8. E. W. Abel, I. S. Butler, and J. G. Reid, “382. The anionic halogenopentacarbonyls of chromium, molybdenum, and tungsten,” Journal of the Chemical Society, p. 2068, 1963. View at Publisher · View at Google Scholar
  9. A. C. Kautz, P. C. Kunz, and C. Janiak, “CO-releasing molecule (CORM) conjugate systems,” Dalton Transactions, vol. 45, no. 45, pp. 18045–18063, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Wright and J. A. Wright, “PhotoCORMs: CO release moves into the visible,” Dalton Transactions, vol. 45, no. 16, pp. 6801–6811, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Schatzschneider, “Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs),” British Journal of Pharmacology, vol. 172, no. 6, pp. 1638–1650, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. S. García-Gallego and G. J. L. Bernardes, “Carbon-monoxide-releasing molecules for the delivery of therapeutic co in vivo,” Angewandte Chemie International Edition, vol. 53, no. 37, pp. 9712–9721, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Gonzales and P. K. Mascharak, “Photoactive metal carbonyl complexes as potential agents for targeted CO delivery,” Journal of Inorganic Biochemistry, vol. 133, pp. 127–135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Steiger, C. Hermann, and L. Meinel, “Localized delivery of carbon monoxide,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 118, pp. 3–12, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Ward, “Carbon monoxide-releasing molecules: therapeutic molecules with a wide variety of medical applications,” in Organometallic Chemistry, vol. 40, pp. 140–176, The Royal Society of Chemistry, London, UK, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Ling, F. Men, W. C. Wang, Y. Q. Zhou, H. W. Zhang, and D. W. Ye, “Carbon monoxide and its controlled release—therapeutic application, detection and development of carbon monoxide-releasing molecules (CO-RMs),” Journal of Medicinal Chemistry, vol. 61, no. 7, pp. 2611–2635, 2017. View at Publisher · View at Google Scholar
  17. C. S. Bang, R. Kruse, K. Johansson, and K. Persson, “Carbon monoxide releasing molecule-2 (CORM-2) inhibits growth of multidrug-resistant uropathogenic Escherichia coli in biofilm and following host cell colonization,” BMC Microbiology, vol. 16, no. 1, p. 64, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Tinajero-Trejo, N. Rana, C. Nagel et al., “Antimicrobial activity of the manganese photoactivated carbon monoxide-releasing molecule [Mn(CO)3(tpa-κ3N)]+ against a pathogenic Escherichia coli that causes urinary infections,” Antioxidants and Redox Signaling, vol. 24, no. 14, pp. 765–780, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Ward, J. M. Lynam, J. Moir, and I. J. S. Fairlamb, “Visible-light-induced CO release from a therapeutically viable tryptophan-derived manganese(I) carbonyl (TryptoCORM) exhibiting potent inhibition against E. coli,” Chemistry-A European Journal, vol. 20, no. 46, pp. 15061–15068, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Ward, R. Morgan, J. M. Lynam, I. J. S. Fairlamb, and J. W. B. Moir, “Toxicity of tryptophan manganese(i) carbonyl (Trypto-CORM), against Neisseria gonorrhoeae,” Medicinal Chemistry Communication, vol. 8, no. 2, pp. 346–352, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. A. F. Tavares, M. R. Parente, M. C. Justino, M. Oleastro, L. S. Nobre, and L. M. Saraiva, “The bactericidal activity of carbon monoxide-releasing molecules against helicobacter pylori,” PLoS One, vol. 8, no. 12, Article ID e83157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Rana, S. McLean, B. E. Mann, and R. K. Poole, “Interaction of the carbon monoxide-releasing molecule Ru(CO)3Cl(glycinate) (CORM-3) with Salmonella enterica serovar Typhimurium: in situ measurements of carbon monoxide binding by integrating cavity dual-beam spectrophotometry,” Microbiology, vol. 160, no. 12, pp. 2771–2779, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Desmard, R. Foresti, D. Morin et al., “Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules,” Antioxidants and Redox Signaling, vol. 16, no. 2, pp. 153–163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Flanagan, R. R. Steen, K. Saxby et al., “The antimicrobial activity of a carbon monoxide releasing molecule (EBOR-CORM-1) is shaped by intraspecific variation within Pseudomonas aeruginosa populations,” Frontiers in Microbiology, vol. 9, 2018. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Almeida, U. Sonnewald, P. M. Alves, and H. L. A. Vieira, “Carbon monoxide improves neuronal differentiation and yield by increasing the functioning and number of mitochondria,” Journal of Neurochemistry, vol. 138, no. 3, pp. 423–435, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Xie, P. Han, Z. Cui et al., “Pretreatment of mouse neural stem cells with carbon monoxide-releasing molecule-2 interferes with NF-κB p65 signaling and suppresses iron overload-induced apoptosis,” Cellular and Molecular Neurobiology, vol. 36, no. 8, pp. 1343–1351, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Wang, L. Yao, L. L. Zhou et al., “Carbon monoxide improves neurologic outcomes by mitochondrial biogenesis after global cerebral ischemia induced by cardiac arrest in rats,” International Journal of Biological Sciences, vol. 12, no. 8, pp. 1000–1009, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Schallner, C. C. Romão, J. Biermann et al., “Carbon monoxide abrogates ischemic insult to neuronal cells via the soluble guanylate cyclase-cGMP pathway,” PLoS One, vol. 8, no. 4, Article ID e60672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. C. Pena, N. Penacho, L. Mancio-Silva et al., “A novel carbon monoxide-releasing molecule fully protects mice from severe malaria,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 3, pp. 1281–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. I. Woo, S. H. Kil, S. Oh et al., “IL-10/HMOX1 signaling modulates cochlear inflammation via negative regulation of MCP-1/CCL2 expression in cochlear fibrocytes,” Journal of Immunology, vol. 194, no. 8, pp. 3953–3961, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. G. Bani-Hani, “Modulation of thrombin-induced neuroinflammation in BV-2 microglia by carbon monoxide-releasing molecule 3,” Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 3, pp. 1315–1322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. C. Lin, C. C. Yang, L. D. Hsiao, S. Y. Chen, and C. M. Yang, “Heme oxygenase-1 induction by carbon monoxide releasing molecule-3 suppresses interleukin-1β-mediated neuroinflammation,” Frontiers in Molecular Neuroscience, vol. 10, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Castany, M. Carcolé, S. Leánez, and O. Pol, “The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice,” Psychopharmacology, vol. 233, no. 11, pp. 2209–2219, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Hervera, S. Leánez, R. Motterlini, and O. Pol, “Treatment with carbon monoxide-releasing molecules and an HO-1 inducer enhances the effects and expression of μ-opioid receptors during neuropathic pain,” Anesthesiology, vol. 118, no. 5, pp. 1180–1197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Nikolic, T. Saksida, M. Vujicic, I. Stojanovic, and S. Stosic-Grujicic, “Anti-diabetic actions of carbon monoxide-releasing molecule (CORM)-A1: immunomodulation and regeneration of islet beta cells,” Immunology Letters, vol. 165, no. 1, pp. 39–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Steiger, K. Uchiyama, T. Takagi et al., “Prevention of colitis by controlled oral drug delivery of carbon monoxide,” Journal of Controlled Release, vol. 239, pp. 128–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Nagao, K. Taguchi, Y. Miyazaki et al., “Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis,” Journal of Controlled Release, vol. 234, pp. 49–58, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Riquelme, S. M. Bueno, and A. M. Kalergis, “Carbon monoxide down-modulates toll-like receptor 4/MD2 expression on innate immune cells and reduces endotoxic shock susceptibility,” Immunology, vol. 144, no. 2, pp. 321–332, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Y. Yeh, C. Y. Li, C. W. Hsieh, Y. C. Yang, P. M. Yang, and B. S. Wung, “CO-releasing molecules and increased heme oxygenase-1 induce protein S-glutathionylation to modulate NF-κB activity in endothelial cells,” Free Radical Biology and Medicine, vol. 70, pp. 1–13, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Maruyama, E. Morishita, T. Yuno et al., “Carbon monoxide (CO)-releasing molecule-derived CO regulates tissue factor and plasminogen activator inhibitor type 1 in human endothelial cells,” Thrombosis Research, vol. 130, no. 3, pp. e188–e193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Fagone, K. Mangano, S. Mammana et al., “Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats,” Clinical Immunology, vol. 157, no. 2, pp. 198–204, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Negrete, A. Hervera, S. Leánez, and O. Pol, “Treatment with a carbon monoxide-releasing molecule inhibits chronic inflammatory pain in mice: nitric oxide contribution,” Psychopharmacology, vol. 231, no. 5, pp. 853–861, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Mu, C. Pan, S. Zheng et al., “Protective effects of carbon monoxide-releasing molecule-2 on the barrier function of intestinal epithelial cells,” PLoS One, vol. 9, no. 8, Article ID e104032, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Y. Choi, S. H. Choe, J. Y. Hyeon, J. Choi, I. S. Choi, and S. J. Kim, “Carbon monoxide-releasing molecule-3 suppresses Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1β in murine macrophages,” European Journal of Pharmacology, vol. 764, pp. 22–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. E. K. Patterson, D. D. Fraser, A. Capretta, R. F. Potter, and G. Cepinskas, “Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction,” Free Radical Biology and Medicine, vol. 70, pp. 167–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Sun, X. Zou, Y. Chen, P. Zhang, and G. Shi, “Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC,” International Journal of Biological Sciences, vol. 4, no. 5, pp. 270–278, 2008. View at Publisher · View at Google Scholar
  47. S. Zhang, S. Zheng, X. Wang et al., “Carbon monoxide-releasing molecule-2 reduces intestinal epithelial tight-junction damage and mortality in septic rats,” PLoS One, vol. 10, no. 12, Article ID e0145988, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Lee, S. J. Lee, A. A. Coronata et al., “Carbon monoxide confers protection in sepsis by enhancing beclin 1-dependent autophagy and phagocytosis,” Antioxidants and Redox Signaling, vol. 20, no. 3, pp. 432–442, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Unuma, T. Aki, K. Noritake, T. Funakoshi, and K. Uemura, “A CO-releasing molecule prevents annexin A2 down-regulation and associated disorders in LPS-administered rat lung,” Biochemical and Biophysical Research Communications, vol. 487, no. 3, pp. 748–754, 2017. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Zhang, A. Tao, T. Lan et al., “Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts,” Basic Research in Cardiology, vol. 112, no. 2, p. 16, 2017. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Liu, F. Liang, X. Wang, J. Cao, W. Qin, and B. Sun, “Suppressive effect of CORM-2 on LPS-induced platelet activation by glycoprotein mediated HS1 phosphorylation interference,” PLoS One, vol. 8, no. 12, Article ID e83112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Liang, J. Cao, W. T. Qin, X. Wang, X. F. Qiu, and B. W. Sun, “Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice,” World Journal of Gastroenterology, vol. 20, no. 12, pp. 3301–3311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Serizawa, E. Patterson, R. F. Potter, D. D. Fraser, and G. Cepinskas, “Pretreatment of human cerebrovascular endothelial cells with CO-releasing molecule-3 interferes with JNK/AP-1 signaling and suppresses LPS-induced proadhesive phenotype,” Microcirculation, vol. 22, no. 1, pp. 28–36, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. P. A. Hosick, A. A. AlAmodi, M. W. Hankins, and D. E. Stec, “Chronic treatment with a carbon monoxide releasing molecule reverses dietary induced obesity in mice,” Adipocyte, vol. 5, no. 1, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  55. M. Zheng, Q. Zhang, Y. Joe et al., “Carbon monoxide-releasing molecules reverse leptin resistance induced by endoplasmic reticulum stress,” American Journal of Physiology-Endocrinology and Metabolism, vol. 304, no. 7, pp. E780–E788, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Ahmad, P. W. Hewett, T. Fujisawa et al., “Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation,” Thrombosis and Haemostasis, vol. 113, no. 2, pp. 329–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Fayad-Kobeissi, J. Ratovonantenaina, H. Dabiré et al., “Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule,” Biochemical Pharmacology, vol. 102, pp. 64–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Loureiro, G. J. L. Bernardes, U. Shimanovich et al., “Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors,” Nanomedicine: Nanotechnology, Biology and Medicine, vol. 11, no. 5, pp. 1077–1083, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. C. I. Schwer, P. Stoll, S. Rospert et al., “Carbon monoxide releasing molecule-2 CORM-2 represses global protein synthesis by inhibition of eukaryotic elongation factor eEF2,” The International Journal of Biochemistry and Cell Biology, vol. 45, no. 2, pp. 201–212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Niesel, A. Pinto, H. W. Peindy N’Dongo et al., “Photoinduced CO release, cellular uptake and cytotoxicity of a tris(pyrazolyl)methane (tpm) manganese tricarbonyl complex,” Chemical Communications, no. 15, p. 1798, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Chigaev, Y. Smagley, and L. A. Sklar, “Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization,” BMC Immunology, vol. 15, no. 1, p. 52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Nassour, B. Kautza, M. Rubin et al., “Carbon monoxide protects against hemorrhagic shock and resuscitation-induced microcirculatory injury and tissue injury,” Shock, vol. 43, no. 2, pp. 166–171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Sener, K. C. Tran, J. P. Deng et al., “Carbon monoxide releasing molecules inhibit cell death resulting from renal transplantation related stress,” Journal of Urology, vol. 190, no. 2, pp. 772–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Yao, P. Wang, M. Chen et al., “Carbon monoxide-releasing molecules attenuate postresuscitation myocardial injury and protect cardiac mitochondrial function by reducing the production of mitochondrial reactive oxygen species in a rat model of cardiac arrest,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 20, no. 3, pp. 330–341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. J. E. Clark, “Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule,” Circulation Research, vol. 93, no. 2, pp. 2e–8e, 2003. View at Publisher · View at Google Scholar
  66. M. D. Musameh, C. J. Green, B. E. Mann, B. J. Fuller, and R. Motterlini, “Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide–releasing molecule (CORM-3),” Journal of Heart and Lung Transplantation, vol. 26, no. 11, pp. 1192–1198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Caumartin, J. Stephen, J. P. Deng et al., “Carbon monoxide-releasing molecules protect against ischemia–reperfusion injury during kidney transplantation,” Kidney International, vol. 79, no. 10, pp. 1080–1089, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Magierowski, K. Magierowska, J. Szmyd et al., “Hydrogen sulfide and carbon monoxide protect gastric mucosa compromised by mild stress against alendronate injury,” Digestive Diseases and Sciences, vol. 61, no. 11, pp. 3176–3189, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Bakhautdin, D. Das, P. Mandal et al., “Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice,” Journal of Hepatology, vol. 61, no. 5, pp. 1029–1037, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Mangano, E. Cavalli, S. Mammana et al., “Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis,” Journal of Cellular Physiology, vol. 233, no. 5, pp. 4156–4165, 2018. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Tayem, T. R. Johnson, B. E. Mann, C. J. Green, and R. Motterlini, “Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule,” American Journal of Physiology-Renal Physiology, vol. 290, no. 4, pp. F789–F794, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. E. Yoon, K. S. Lee, Y. J. Lee, H. H. Lee, and W. K. Han, “Renoprotective effects of carbon monoxide–releasing molecule 3 in ischemia-reperfusion injury and cisplatin-induced toxicity,” Transplantation Proceedings, vol. 49, no. 5, pp. 1175–1182, 2017. View at Publisher · View at Google Scholar · View at Scopus
  73. O. De Backer, E. Elinck, B. Blanckaert, L. Leybaert, R. Motterlini, and R. A. Lefebvre, “Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress,” Gut, vol. 58, no. 3, pp. 347–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Abid, A. Houssaini, N. Mouraret et al., “p21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 2, pp. 304–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. O. Pak, A. G. Bakr, M. Gierhardt et al., “Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs,” Journal of Applied Physiology, vol. 120, no. 2, pp. 271–281, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. E. Stagni, M. G. Privitera, C. Bucolo, G. M. Leggio, R. Motterlini, and F. Drago, “A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits,” British Journal of Ophthalmology, vol. 93, no. 2, pp. 254–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Soni, G. Pandya, P. Patel, A. Acharya, M. Jain, and A. A. Mehta, “Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: Role of oxidative stress and apoptosis,” Toxicology and Applied Pharmacology, vol. 253, no. 1, pp. 70–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. M. H. Tsai, C. W. Lee, L. F. Hsu et al., “CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression,” Redox Biology, vol. 12, pp. 377–388, 2017. View at Publisher · View at Google Scholar · View at Scopus
  79. H. Segersvärd, P. Lakkisto, M. Hänninen et al., “Carbon monoxide releasing molecule improves structural and functional cardiac recovery after myocardial injury,” European Journal of Pharmacology, vol. 818, pp. 57–66, 2018. View at Publisher · View at Google Scholar · View at Scopus
  80. V. G. Nielsen, J. K. Kirklin, and J. F. George, “Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma,” Blood Coagulation and Fibrinolysis, vol. 20, no. 5, pp. 377–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. V. G. Nielsen, N. Chawla, D. Mangla et al., “Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits,” Blood Coagulation and Fibrinolysis, vol. 22, no. 8, pp. 756–759, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. K. A. Machovec, D. S. Ushakumari, I. J. Welsby, and V. G. Nielsen, “The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2,” Thrombosis Research, vol. 129, no. 6, pp. 793–796, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. V. G. Nielsen and C. M. Bazzell, “Carbon monoxide attenuates the effects of snake venoms containing metalloproteinases with fibrinogenase or thrombin-like activity on plasmatic coagulation,” Medicinal Chemistry Communications, vol. 7, no. 10, pp. 1973–1979, 2016. View at Publisher · View at Google Scholar · View at Scopus
  84. V. G. Nielsen, V. L. Boyer, R. W. Matika, Q. Amos, and D. T. Redford, “Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis,” Blood Coagulation and Fibrinolysis, vol. 27, no. 5, pp. 511–516, 2016. View at Publisher · View at Google Scholar · View at Scopus
  85. V. G. Nielsen and C. M. Bazzell, “Carbon monoxide releasing molecule-2 inhibition of snake venom thrombin-like activity: novel biochemical “brake”?” Journal of Thrombosis and Thrombolysis, vol. 43, no. 2, pp. 203–208, 2017. View at Publisher · View at Google Scholar · View at Scopus
  86. V. G. Nielsen, “Crotalus atrox venom exposed to carbon monoxide has decreased fibrinogenolytic activity in vivo in rabbits,” Basic and Clinical Pharmacology and Toxicology, vol. 122, no. 1, pp. 82–86, 2018. View at Publisher · View at Google Scholar · View at Scopus
  87. B. Chen, L. Guo, C. Fan et al., “Carbon monoxide rescues heme oxygenase-1-deficient mice from arterial thrombosis in allogeneic aortic transplantation,” American Journal of Pathology, vol. 175, no. 1, pp. 422–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Kramkowski, A. Leszczynska, A. Mogielnicki et al., “Antithrombotic properties of water-soluble carbon monoxide-releasing molecules,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2149–2157, 2012. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Klinger-Strobel, S. Gläser, O. Makarewicz et al., “Bactericidal effect of a photoresponsive carbon monoxide-releasing nonwoven against Staphylococcus aureus biofilms,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 7, pp. 4037–4046, 2016. View at Publisher · View at Google Scholar · View at Scopus
  90. J. L. Wilson, L. K. Wareham, S. McLean et al., “CO-releasing molecules have nonheme targets in bacteria: transcriptomic, mathematical modeling and biochemical analyses of CORM-3 [Ru(CO)3Cl(glycinate)] actions on a heme-deficient mutant of Escherichia coli,” Antioxidants and Redox Signaling, vol. 23, no. 2, pp. 148–162, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Verma, D. Hirsch, C. Glatt, G. Ronnett, and S. Snyder, “Carbon monoxide: a putative neural messenger,” Science, vol. 259, no. 5093, pp. 381–384, 1993. View at Publisher · View at Google Scholar
  92. R. Battish, G. Y. Cao, R. B. Lynn, S. Chakder, and S. Rattan, “Heme-oxygenase 2 (HO-2) distribution in anorectum of opossum: colocalization with neuronal nitric oxide synthase (nNOS) and vasoactive intestinal polypeptide (VIP),” Gastroenterology, vol. 114, p. A719, 1998. View at Publisher · View at Google Scholar
  93. L. Xue, G. Farrugia, S. M. Miller, C. D. Ferris, S. H. Snyder, and J. H. Szurszewski, “Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes,” Proceedings of the National Academy of Sciences, vol. 97, no. 4, pp. 1851–1855, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Henke, N. E. Kroll, H. Behniea et al., “Memory lost and regained following bilateral hippocampal damage,” Journal of Cognitive Neuroscience, vol. 11, no. 6, pp. 682–697, 1999. View at Publisher · View at Google Scholar · View at Scopus
  95. C. Mancuso, E. Ragazzoni, G. Tringali et al., “Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat,” Journal of Neuroimmunology, vol. 99, no. 2, pp. 189–194, 1999. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Y. Calingasan, W. J. Chun, L. C. H. Park, K. Uchida, and G. E. Gibson, “Oxidative stress is associated with region-specific neuronal death during thiamine deficiency,” Journal of Neuropathology and Experimental Neurology, vol. 58, no. 9, pp. 946–958, 1999. View at Publisher · View at Google Scholar
  97. I. S. Choi and H. Y. Cheon, “Delayed movement disorders after carbon monoxide poisoning,” European Neurology, vol. 42, no. 3, pp. 141–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  98. H. M. Schipper, A. Liberman, and E. G. Stopa, “Neural heme oxygenase-1 expression in idiopathic Parkinson’s disease,” Experimental Neurology, vol. 150, no. 1, pp. 60–68, 1998. View at Publisher · View at Google Scholar · View at Scopus
  99. C. A. Piantadosi, J. Zhang, E. D. Levin, R. J. Folz, and D. E. Schmechel, “Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat,” Experimental Neurology, vol. 147, no. 1, pp. 103–114, 1997. View at Publisher · View at Google Scholar · View at Scopus
  100. A. C. Durak, A. Coskun, A. Yikilmaz, F. Erdogan, E. Mavili, and M. Guven, “Magnetic resonance imaging findings in chronic carbon monoxide intoxication,” Acta Radiologica, vol. 46, no. 3, pp. 322–327, 2005. View at Publisher · View at Google Scholar · View at Scopus
  101. C. S. F. Queiroga, R. M. A. Alves, S. V. Conde, P. M. Alves, and H. L. A. Vieira, “Paracrine effect of carbon monoxide–astrocytes promote neuroprotection through purinergic signaling in mice,” Journal of Cell Science, vol. 129, no. 16, pp. 3178–3188, 2016. View at Publisher · View at Google Scholar · View at Scopus
  102. T. Simon, S. Pogu, V. Tardif et al., “Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8+T cells and protect from type 1 diabetes,” European Journal of Immunology, vol. 43, no. 1, pp. 209–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. S. S. Jung, J. S. Moon, J. F. Xu et al., “Carbon monoxide negatively regulates NLRP3 inflammasome activation in macrophages,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 308, no. 10, pp. L1058–L1067, 2015. View at Publisher · View at Google Scholar · View at Scopus
  104. A. Bougié, A. Harrois, and J. Duranteau, “Resuscitative strategies in traumatic hemorrhagic shock,” Annals of Intensive Care, vol. 3, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Takagi, Y. Naito, K. Uchiyama et al., “Carbon monoxide promotes gastric wound healing in mice via the protein kinase C pathway,” Free Radical Research, vol. 50, no. 10, pp. 1098–1105, 2016. View at Publisher · View at Google Scholar · View at Scopus
  106. J. A. Nemzek, C. Fry, and O. Abatan, “Low-dose carbon monoxide treatment attenuates early pulmonary neutrophil recruitment after acid aspiration,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 294, no. 4, pp. L644–L653, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. J. T. Chapman, L. E. Otterbein, J. A. Elias, and A. M. K. Choi, “Carbon monoxide attenuates aeroallergen-induced inflammation in mice,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 281, no. 1, pp. L209–L216, 2001. View at Publisher · View at Google Scholar
  108. L. E. Otterbein, S. L. Otterbein, E. Ifedigbo et al., “MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury,” American Journal of Pathology, vol. 163, no. 6, pp. 2555–2563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  109. T. Dolinay, M. Szilasi, M. Liu, and A. M. K. Choi, “Inhaled carbon monoxide confers antiinflammatory effects against ventilator-induced lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 6, pp. 613–620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. A. M. Aberg, P. Abrahamsson, G. Johansson, M. Haney, O. Winso, and J. E. Larsson, “Does carbon monoxide treatment alter cytokine levels after endotoxin infusion in pigs? A randomized controlled study,” Journal of Inflammation, vol. 5, no. 1, pp. 13–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. L. A. Mitchell, M. M. Channell, C. M. Royer, S. W. Ryter, A. M. K. Choi, and J. D. McDonald, “Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inflammation,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 299, no. 6, pp. L891–L897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. C. Bucolo and F. Drago, “Carbon monoxide and the eye: implications for glaucoma therapy,” Pharmacology and Therapeutics, vol. 130, no. 2, pp. 191–201, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. R. F. Anderson, “Myocardial toxicity from carbon monoxide poisoning,” Annals of Internal Medicine, vol. 67, no. 6, p. 1172, 1967. View at Publisher · View at Google Scholar
  114. R. Favory, S. Lancel, S. Tissier, D. Mathieu, B. Decoster, and R. Nevière, “Myocardial dysfunction and potential cardiac hypoxia in rats induced by carbon monoxide inhalation,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 3, pp. 320–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. L. Andre, J. Boissière, C. Reboul et al., “Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 6, pp. 587–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. D. V. Abramochkin, O. P. Konovalova, A. Kamkin, and G. F. Sitdikova, “Carbon monoxide modulates electrical activity of murine myocardium via cGMP-dependent mechanisms,” Journal of Physiology and Biochemistry, vol. 71, no. 1, pp. 107–119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  117. R. D. Stewart, “The effect of carbon monoxide on humans,” Annual Review of Pharmacology, vol. 15, no. 1, pp. 409–423, 1975. View at Publisher · View at Google Scholar
  118. L. W. Kao and K. A. Nañagas, “Toxicity associated with carbon monoxide,” Clinics in Laboratory Medicine, vol. 26, no. 1, pp. 99–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. R. Foresti, M. G. Bani-Hani, and R. Motterlini, “Use of carbon monoxide as a therapeutic agent: promises and challenges,” Intensive Care Medicine, vol. 34, no. 4, pp. 649–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. National Research Council (US) Committee on Acute Exposure Guideline Levels, “Carbon monoxide acute exposure guideline levels,” in Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 8, pp. 49–143, National Academies Press (US), Washington, DC, USA, 2010. View at Google Scholar
  121. K. Magierowska, M. Magierowski, M. Hubalewska-Mazgaj et al., “Carbon monoxide (CO) released from tricarbonyldichlororuthenium (II) dimer (CORM-2) in gastroprotection against experimental ethanol-induced gastric damage,” PLoS One, vol. 10, no. 10, Article ID e0140493, 2015. View at Publisher · View at Google Scholar · View at Scopus
  122. G. Wang, T. Hamid, R. J. Keith et al., “Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart,” Circulation, vol. 121, no. 17, pp. 1912–1925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. B. Wegiel, D. W. Hanto, and L. E. Otterbein, “The social network of carbon monoxide in medicine,” Trends in Molecular Medicine, vol. 19, no. 1, pp. 3–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. J. D. Seixas, M. F. A. Santos, A. Mukhopadhyay et al., “A contribution to the rational design of Ru(CO)3Cl2L complexes for in vivo delivery of CO,” Dalton Transactions, vol. 44, no. 11, pp. 5058–5075, 2015. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Feger, A. Fajol, A. Lebedeva et al., “Effect of carbon monoxide donor CORM-2 on vitamin D3 metabolism,” Kidney and Blood Pressure Research, vol. 37, no. 4-5, pp. 496–505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. E. Lang, S. M. Qadri, K. Jilani, A. Lupescu, E. Schleicheeer, and T. Lang, “Carbon monoxide-sensitive apoptotic death of erythrocytes,” Basic and Clinical Pharmacology and Toxicology, vol. 111, no. 5, pp. 348–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. I. C. Winburn, K. Gunatunga, R. D. McKernan, R. J. Walker, I. A. Sammut, and J. C. Harrison, “Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications,” Basic and Clinical Pharmacology and Toxicology, vol. 111, no. 1, pp. 31–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. P. Wang, H. Liu, Q. Zhao et al., “Syntheses and evaluation of drug-like properties of CO-releasing molecules containing ruthenium and group 6 metal,” European Journal of Medicinal Chemistry, vol. 74, pp. 199–215, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. R. Motterlini, P. Sawle, J. Hammad et al., “Vasorelaxing effects and inhibition of nitric oxide in macrophages by new iron-containing carbon monoxide-releasing molecules (CO-RMs),” Pharmacological Research, vol. 68, no. 1, pp. 108–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Romanski, B. Kraus, U. Schatzschneider, J. M. Neudörfl, S. Amslinger, and H. G. Schmalz, “Acyloxybutadiene iron tricarbonyl complexes as enzyme-triggered CO-releasing molecules (ET-CORMs),” Angewandte Chemie International Edition, vol. 50, no. 10, pp. 2392–2396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. R. Mede, P. Hoffmann, C. Neumann et al., “Acetoxymethyl concept for intracellular administration of carbon monoxide with Mn(CO)3-based photoCORMs,” Chemistry-A European Journal, vol. 24, no. 13, pp. 3321–3329, 2018. View at Publisher · View at Google Scholar · View at Scopus
  132. G. Dördelmann, T. Meinhardt, T. Sowik, A. Krueger, and U. Schatzschneider, “CuAAC click functionalization of azide-modified nanodiamond with a photoactivatable CO-releasing molecule (PhotoCORM) based on [Mn(CO)3(tpm)]+,” Chemical Communications, vol. 48, no. 94, Article ID 11528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. U. Hasegawa, A. J. van der Vlies, E. Simeoni, C. Wandrey, and J. A. Hubbell, “Carbon monoxide-releasing micelles for immunotherapy,” Journal of the American Chemical Society, vol. 132, no. 51, pp. 18273–18280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  134. P. Govender, S. Pai, U. Schatzschneider, and G. S. Smith, “Next generation PhotoCORMs: polynuclear tricarbonylmanganese(I)-functionalized polypyridyl metallodendrimers,” Inorganic Chemistry, vol. 52, no. 9, pp. 5470–5478, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. R. Motterlini, P. Sawle, J. Hammad et al., “CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule,” FASEB Journal, vol. 19, no. 2, pp. 284–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  136. A. E. Pierri, A. Pallaoro, G. Wu, and P. C. Ford, “A luminescent and biocompatible PhotoCORM,” Journal of the American Chemical Society, vol. 134, no. 44, pp. 18197–18200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  137. S. J. Carrington, I. Chakraborty, J. M. L. Bernard, and P. K. Mascharak, “A theranostic two-tone luminescent PhotoCORM derived from Re(I) and (2-pyridyl)-benzothiazole: trackable CO delivery to malignant cells,” Inorganic Chemistry, vol. 55, no. 16, pp. 7852–7858, 2016. View at Publisher · View at Google Scholar · View at Scopus
  138. G. Ur, J. Axthelm, P. Hoffmann et al., “Co-registered molecular logic gate with a CO-releasing molecule triggered by light and peroxide,” Journal of the American Chemical Society, vol. 139, no. 14, pp. 4991–4994, 2017. View at Publisher · View at Google Scholar · View at Scopus
  139. G. Gessner, N. Sahoo, S. M. Swain et al., “CO-independent modification of K+ channels by tricarbonyldichlororuthenium(II) dimer (CORM-2),” European Journal of Pharmacology, vol. 812, pp. 33–41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. C Nagel, McLean, R. K Poole, H. Braunschweig, T. Kramer, and U. Schatzschneider, “Introducing [Mn(CO)3(tpa-κ3N)]+ as a novel photoactivatable CO-releasing molecule with well-defined iCORM intermediates–synthesis, spectroscopy, and antibacterial activity,” Dalton Transactions, vol. 43, no. 26, pp. 9986–9997, 2014. View at Publisher · View at Google Scholar · View at Scopus
  141. T. Santos-Silva, A. Mukhopadhyay, J. D. Seixas, J. L. Bernardes, C. Romao, and M. Romao, “Towards therapeutic CORMs: understanding the reactivity of CORM-3 with proteins,” Current Medicinal Chemistry, vol. 18, no. 22, pp. 3361–3366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  142. B. E. Mann, “3.29 signaling molecule delivery (CO),” in Comprehensive Inorganic Chemistry (II), J. Reedjik and K. Poeppelmeier, Eds., pp. 857–876, Elsevier, Amsterdam, Netherlands, 2nd edition, 2013. View at Publisher · View at Google Scholar
  143. S. M. Kapetanaki, G. Slikstoner, I. Husu, U. Liebl, M. T. Wilson, and M. H. Vos, “Interaction of carbon monixide with apoptosis—inducing cyytochrome C–cardiolipin complex,” Biochemistry, vol. 48, no. 7, pp. 1613–1619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Ibrahim, E. R. Derbyshire, M. A. Marletta, and T. G. Spiro, “Probing soluble guanylate cyclase actgivation by CO and YC-1 usiong resonance Raman spectroscopy,” Biochemistry, vol. 49, no. 18, pp. 3815–3823, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. X. Ji and B. Wang, “Strategies toward organic carbon monoxide prodrugs,” Accounts of Chemical Research, vol. 51, no. 6, pp. 1377–1385, 2018. View at Publisher · View at Google Scholar
  146. Z. Pan, J. Zhang, K. Ji, V. Chittavong, X. Ji, and W. Wang, “Organic CO prodrugs activated by endogenous ROS,” Organic Letters, vol. 20, no. 1, pp. 8–11, 2018. View at Publisher · View at Google Scholar · View at Scopus
  147. S. T. Blackburn, Maternal, Fetal, & Neonatal Physiology: A Clinical Perspective, Elsevier Health Sciences, Gurgaeon, Harvana, India, 2007.